Effects of structured exercise regime on lipid profile and renal function tests in gestational diabetes mellitus

Wardah Ajaz Qazi1, Muhammad Naveed Babur2, Arshad Nawaz Malik3

  • 1Institute of Rehabilitation Sciences (FUIRS), Foundation University Islamabad.

Abstract

Insights

This pilot study investigated the impact of a structured exercise program on gestational diabetes mellitus patients. While showing promise in reducing LDL cholesterol and creatinine, the study faced significant design and statistical limitations.

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Sports Medicine

Background:

  • Gestational diabetes mellitus (GDM) poses risks to maternal and fetal health.
  • Management of GDM often involves lifestyle modifications, including exercise.
  • Evidence on the specific effects of structured exercise on biochemical markers in GDM is evolving.

Purpose of the Study:

  • To evaluate the impact of a 5-week structured exercise regimen on lipid profiles and renal function tests in patients with GDM.
  • To assess changes in serum low-density lipoprotein (LDL) and serum creatinine levels in GDM patients undergoing exercise intervention.

Main Methods:

  • A two-arm pilot study involving 16 women aged 20-40 with GDM.
  • Randomization into an intervention group (structured exercise) and a control group (postural education).
  • Data collection at baseline and post-intervention, with statistical analysis using SPSS 20.

Main Results:

  • Significant reductions in serum low-density lipoprotein (LDL) and serum creatinine were observed in the intervention group compared to the control group (p<0.05).
  • Other biochemical markers did not show statistically significant differences between the groups (p>0.05).

Conclusions:

  • A structured exercise regime demonstrated a potential positive effect on reducing LDL cholesterol and serum creatinine in GDM patients during the third trimester.
  • The study's small sample size and methodological concerns necessitate cautious interpretation of findings and further research.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
416
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
373
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
62
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
327